ArticleEuropean journal of medical research2023

Roxadustat alleviates the inflammatory status in patients receiving maintenance hemodialysis with erythropoiesis-stimulating agent resistance by increasing the short-chain fatty acids producing gut bacteria.

Xiu-Nan Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.